These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2199394)

  • 21. Clinical evaluation of patients with prostatic obstruction: correlation of flow rates with voided, residual or total bladder volume.
    Drach GW; Steinbronn DV
    J Urol; 1986 Apr; 135(4):737-40. PubMed ID: 2421016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of endocrine and radiation therapy in locally advanced prostatic cancer.
    Aro J; Haapiainen R; Kajanti M; Rannikko S; Alfthan O
    Eur Urol; 1988; 15(3-4):182-6. PubMed ID: 3063541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radical prostatectomy restores detrusor contraction pattern according to pressure flow parameters.
    Kitta T; Kanno Y; Chiba H; Moriya K; Maruyama S; Abe T; Shinohara N
    Int J Urol; 2017 Apr; 24(4):301-307. PubMed ID: 28122392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parenteral polyoestradiol phosphate vs orchidectomy in the treatment of advanced prostatic cancer. Efficacy and cardiovascular complications: a 2-year follow-up report of a national, prospective prostatic cancer study. Finnprostate Group.
    Mikkola AK; Ruutu ML; Aro JL; Rannikko SA; Salo JO
    Br J Urol; 1998 Jul; 82(1):63-8. PubMed ID: 9698663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of a long-acting LHRH agonist and polyoestradiol phosphate in the treatment of advanced prostatic carcinoma. An open prospective, randomized multicentre study.
    Lukkarinen O; Kontturi M
    Scand J Urol Nephrol; 1994 Jun; 28(2):171-8. PubMed ID: 7939468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detrusor pressure in bladder outlet obstruction.
    Anikwe RM
    Urology; 1978 Aug; 12(2):225-30. PubMed ID: 80872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermediate-term efficacy of Tm:YAG laser prostate vaporesection for bladder outlet obstruction: initial experience from a UK teaching hospital.
    Pal RP; Khan MA
    Urol Int; 2012; 88(1):39-42. PubMed ID: 22133639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neodymium:YAG laser coagulation prostatectomy: 3 years of experience with 227 patients.
    Kabalin JN; Bite G; Doll S
    J Urol; 1996 Jan; 155(1):181-5. PubMed ID: 7490827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Data from frequency-volume charts versus maximum free flow rate, residual volume, and voiding cystometric estimated urethral obstruction grade and detrusor contractility grade in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Van Venrooij GE; Eckhardt MD; Boon TA
    Neurourol Urodyn; 2002; 21(5):450-6. PubMed ID: 12232879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased urinary nerve growth factor reflects prostatic volume reduction and relief of outlet obstruction in patients with benign prostatic enlargement treated with dutasteride.
    Wada N; Matsumoto S; Kita M; Hashizume K; Kakizaki H
    Int J Urol; 2014 Dec; 21(12):1258-62. PubMed ID: 25039474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Video-urodynamics study on female patients with bladder neck obstruction.
    Zhang P; Yang Y; Wu ZJ; Zhang XD; Zhang CH
    Chin Med J (Engl); 2012 Apr; 125(8):1425-8. PubMed ID: 22613647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of bladder outlet obstruction and detrusor contractility on residual urine in patients with benign prostatic hyperplasia.
    Zhang P; Wu Z; Gao J
    Chin Med J (Engl); 2003 Oct; 116(10):1508-10. PubMed ID: 14570611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urodynamic effects of finasteride in the treatment of bladder outlet obstruction due to benign prostatic hyperplasia.
    Tammela TL; Kontturi MJ
    J Urol; 1993 Feb; 149(2):342-4. PubMed ID: 7678871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detrusor instability as an energy-saving device in prostatic obstruction.
    Cucchi A; Achilli MP; Ravasi S; Arrigoni N
    J Urol; 1997 Mar; 157(3):866-70. PubMed ID: 9072588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular and all-cause mortality in prostatic cancer patients treated with estrogens or orchiectomy as compared to the standard population.
    Aro J
    Prostate; 1991; 18(2):131-7. PubMed ID: 2006119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct recording of urethral resistance using the "urethroresistance".
    Anikwe RM
    J Urol; 1978 May; 119(5):643-8. PubMed ID: 77916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy and outcome of palliative TURP in patients with bladder outlet obstruction induced by advanced prostate cancer].
    Liu L; Hou XF; Ma LL; Zhao L; Zhang HX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):597-600. PubMed ID: 26284392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radionuclide assessment of bladder outlet obstruction: a noninvasive (1-step) method for measurement of voiding time, urinary flow rates and residual urine.
    Groshar D; Embon OM; Sazbon A; Koritny ES; Frenkel A
    J Urol; 1988 Feb; 139(2):266-9. PubMed ID: 2963143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unravelling detrusor underactivity: Development of a bladder outlet resistance-Bladder contractility nomogram for adult male patients with lower urinary tract symptoms.
    Oelke M; Rademakers KL; van Koeveringe GA;
    Neurourol Urodyn; 2016 Nov; 35(8):980-986. PubMed ID: 26235823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prazosin in the treatment of prostatic obstruction. A placebo-controlled study.
    Kirby RS; Coppinger SW; Corcoran MO; Chapple CR; Flannigan M; Milroy EJ
    Br J Urol; 1987 Aug; 60(2):136-42. PubMed ID: 2444306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.